Finding 417668 (2022-001)

Significant Deficiency Repeat Finding
Requirement
I
Questioned Costs
-
Year
2022
Accepted
2023-06-28
Audit: 312164
Auditor: Eide Bailly LLP

AI Summary

  • Core Issue: Significant deficiencies in internal controls over compliance with procurement standards for federal grants were identified.
  • Impacted Requirements: Non-compliance with Uniform Guidance and 2 CFR sections 200.318-326 regarding documentation for quotes and vendor checks.
  • Recommended Follow-Up: Management should enhance documentation practices and ensure proper oversight to meet procurement requirements and verify vendor eligibility.

Finding Text

2022-001 Department of State ? Bureau of Population, Refugees, and MigrationFederal Financial Assistance Listing #19.517, Overseas Refugee Assistance Programs for AfricaAgency for International DevelopmentDepartment of State - Federal Financial Assistance Listing # 98.001, USAID Foreign Assistance for Programs OverseasProcurement, Suspension and DebarmentType of Finding: Significant Deficiency in Internal Control over ComplianceGrant Award Number: Affects all grant awards included under Federal Financial Assistance Listing #19.517 and #98.001 on the Schedule.Criteria: Uniform Guidance and 2 CFR sections 200.318 through 200.326 set forth the procurement standards non-federal entities, other than states, must follow when operating federal programs and the required procurement procedures based on the amount of the transaction.Condition: CVT has documented procurement procedures that conform to applicable federal standards; however, the procedures were not followed regarding maintaining documentation of obtaining quotes for simplified acquisition small purchases and the conclusion as to which item was selected. In addition, CVT was not testing vendors for suspension and debarment.Cause: Controls were not adequately designed due to lack of oversight, awareness, or understanding of all of the specific requirements under the Uniform Guidance and applicable CFR sections.Effect: The best price for the purchase may not have been obtained and payments could be made to recipients who were suspended or debarred.Questioned Costs: None reported.Context/Sampling: For Federal Financial Assistance Listing #19.517, a nonstatistical sample of 60 transactions out of 2,935 total transactions was selected for testing. Required documentation related to procurement was not maintained for 13 of the items selected, and 13 of the items selected did not have support for suspension and debarment. For Federal Financial Assistance Listing #98.001, a nonstatistical sample of 60 transactions out of 1,594 total transactions were selected for testing. Required documentation related to procurement was not maintained for six of the items selected, and seven of the items selected did not have support for suspension, and debarment.Repeat Finding from Prior Year: Yes, prior year finding 2021-001.Recommendation: We recommend that management maintain adequate supporting documentation and records to document history, methods of procurement, and documentation to support check for suspension and debarment to comply with these CFR sections.Views of Responsible Officials: Management agrees with this finding.

Categories

Procurement, Suspension & Debarment

Other Findings in this Audit

  • 417661 2022-001
    Significant Deficiency Repeat
  • 417662 2022-001
    Significant Deficiency Repeat
  • 417663 2022-001
    Significant Deficiency Repeat
  • 417664 2022-001
    Significant Deficiency Repeat
  • 417665 2022-001
    Significant Deficiency Repeat
  • 417666 2022-001
    Significant Deficiency Repeat
  • 417667 2022-001
    Significant Deficiency Repeat
  • 417669 2022-002
    Material Weakness
  • 417670 2022-002
    Material Weakness
  • 417671 2022-002
    Material Weakness
  • 417672 2022-002
    Material Weakness
  • 417673 2022-002
    Material Weakness
  • 417674 2022-002
    Material Weakness
  • 417675 2022-002
    Material Weakness
  • 417676 2022-002
    Material Weakness
  • 417677 2022-004
    Significant Deficiency
  • 417678 2022-004
    Significant Deficiency
  • 417679 2022-004
    Significant Deficiency
  • 417680 2022-004
    Significant Deficiency
  • 417681 2022-004
    Significant Deficiency
  • 417682 2022-004
    Significant Deficiency
  • 417683 2022-004
    Significant Deficiency
  • 417684 2022-004
    Significant Deficiency
  • 417685 2022-006
    Significant Deficiency
  • 417686 2022-006
    Significant Deficiency
  • 417687 2022-006
    Significant Deficiency
  • 417688 2022-006
    Significant Deficiency
  • 417689 2022-006
    Significant Deficiency
  • 417690 2022-006
    Significant Deficiency
  • 417691 2022-006
    Significant Deficiency
  • 417692 2022-006
    Significant Deficiency
  • 417693 2022-001
    Significant Deficiency Repeat
  • 417694 2022-001
    Significant Deficiency Repeat
  • 417695 2022-001
    Significant Deficiency Repeat
  • 417696 2022-003
    Significant Deficiency
  • 417697 2022-003
    Significant Deficiency
  • 417698 2022-003
    Significant Deficiency
  • 417699 2022-004
    Significant Deficiency
  • 417700 2022-004
    Significant Deficiency
  • 417701 2022-004
    Significant Deficiency
  • 417702 2022-005
    Significant Deficiency
  • 417703 2022-006
    Significant Deficiency
  • 994103 2022-001
    Significant Deficiency Repeat
  • 994104 2022-001
    Significant Deficiency Repeat
  • 994105 2022-001
    Significant Deficiency Repeat
  • 994106 2022-001
    Significant Deficiency Repeat
  • 994107 2022-001
    Significant Deficiency Repeat
  • 994108 2022-001
    Significant Deficiency Repeat
  • 994109 2022-001
    Significant Deficiency Repeat
  • 994110 2022-001
    Significant Deficiency Repeat
  • 994111 2022-002
    Material Weakness
  • 994112 2022-002
    Material Weakness
  • 994113 2022-002
    Material Weakness
  • 994114 2022-002
    Material Weakness
  • 994115 2022-002
    Material Weakness
  • 994116 2022-002
    Material Weakness
  • 994117 2022-002
    Material Weakness
  • 994118 2022-002
    Material Weakness
  • 994119 2022-004
    Significant Deficiency
  • 994120 2022-004
    Significant Deficiency
  • 994121 2022-004
    Significant Deficiency
  • 994122 2022-004
    Significant Deficiency
  • 994123 2022-004
    Significant Deficiency
  • 994124 2022-004
    Significant Deficiency
  • 994125 2022-004
    Significant Deficiency
  • 994126 2022-004
    Significant Deficiency
  • 994127 2022-006
    Significant Deficiency
  • 994128 2022-006
    Significant Deficiency
  • 994129 2022-006
    Significant Deficiency
  • 994130 2022-006
    Significant Deficiency
  • 994131 2022-006
    Significant Deficiency
  • 994132 2022-006
    Significant Deficiency
  • 994133 2022-006
    Significant Deficiency
  • 994134 2022-006
    Significant Deficiency
  • 994135 2022-001
    Significant Deficiency Repeat
  • 994136 2022-001
    Significant Deficiency Repeat
  • 994137 2022-001
    Significant Deficiency Repeat
  • 994138 2022-003
    Significant Deficiency
  • 994139 2022-003
    Significant Deficiency
  • 994140 2022-003
    Significant Deficiency
  • 994141 2022-004
    Significant Deficiency
  • 994142 2022-004
    Significant Deficiency
  • 994143 2022-004
    Significant Deficiency
  • 994144 2022-005
    Significant Deficiency
  • 994145 2022-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.604 Assistance for Torture Victims $428,936
19.519 Overseas Refugee Assistance Program for Near East and South Asia $268,828
93.958 Block Grants for Community Mental Health Services $137,241
98.001 Usaid Foreign Assistance for Programs Overseas $97,304
16.575 Crime Victim Assistance $63,345
19.345 International Programs to Support Democracy, Human Rights and Labor $28,025
93.671 Family Violence Prevention and Services/domestic Violence Shelter and Supportive Services $22,605
19.990 International Justice and Accountability Programming $17,636
93.498 Provider Relief Fund $11,000
19.517 Overseas Refugee Assistance Programs for Africa $7,613